title: CX3CR1-deficiency is associated with increased severity of disease in experimental autoimmune uveitis.
abstract: The role of CX3CR1 in regulating the function of monocytes and microglia was examined in mice in which CX3CR1 had been replaced by green fluorescent protein (GFP). Induction of experimental autoimmune uveitis (EAU) in these mice resulted in increased disease severity at day 23 postimmunization with uveitogenic peptide when compared with CX3CR1-positive mice and increased apoptosis of neuronal cells in the inner nuclear layer. Resident microglia within the retina were activated equally as EAU developed in mice with or without CX3CR1, as determined by changes in morphology, suggesting that the microglial cell response did not account for the differences. Although the inflammatory infiltrate had increased in mice without CX3CR1 at day 23 postimmunization, the percentage of natural killer cells in the infiltrate was not changed in these mice. Similarly, increased disease severity at this stage was not associated with an overall increased percentage of macrophages in the retinal inflammatory infiltrate or in increased activation of these cells. The increased recruitment of monocytes to the retina in response to EAU induction in CX3CR1(GFP/GFP) mice compared with CX3CR1(GFP/+) mice was not reflected in increased migration away from vessels, leading to marked clustering of GFP(+) cells around veins and venules in these mice. It is possible that this monocyte/macrophage clustering leads to the increased severity of disease seen in the mice by focusing and so intensifying the inflammatory response.
authors.affiliation: Division of Applied Medicine, University of Aberdeen, Aberdeen, UK.
authors.forename: Athanasios
authors.initials: A
authors.lastname: Dagkalis
authors.forename: Carol
authors.initials: C
authors.lastname: Wallace
authors.forename: Benjamin
authors.initials: B
authors.lastname: Hing
authors.forename: Janet
authors.initials: J
authors.lastname: Liversidge
authors.forename: Isabel J
authors.initials: IJ
authors.lastname: Crane
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology* / Q000473:pathology; D000073883:CX3C Chemokine Receptor 1; D007694:Killer Cells, Natural / Q000276:immunology; D008262:Macrophage Activation / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D017628:Microglia / Q000276:immunology; D009000:Monocytes / Q000276:immunology; D019707:Receptors, Chemokine / Q000172:deficiency* / Q000235:genetics / Q000276:immunology; D012160:Retina / Q000276:immunology / Q000473:pathology; D014605:Uveitis / Q000276:immunology* / Q000473:pathology
chemical_list: D000073883:CX3C Chemokine Receptor 1; C471885:Cx3cr1 protein, mouse; D019707:Receptors, Chemokine
references.citation: FASEB J. 2006 May;20(7):896-905
references.pmid: 16675847
references.citation: Curr Eye Res. 1998 Apr;17(4):426-37
references.pmid: 9561835
references.citation: Invest Ophthalmol Vis Sci. 1999 Dec;40(13):3177-85
references.pmid: 10586940
references.citation: J Clin Invest. 2007 Apr;117(4):902-9
references.pmid: 17364026
references.citation: Annu Rev Immunol. 2004;22:891-928
references.pmid: 15032599
references.citation: Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1608-15
references.pmid: 12657599
references.citation: J Immunol. 1999 Aug 1;163(3):1628-35
references.pmid: 10415068
references.citation: J Leukoc Biol. 2006 Mar;79(3):435-43
references.pmid: 16365158
references.citation: Kidney Int. 1999 Aug;56(2):612-20
references.pmid: 10432400
references.citation: J Clin Invest. 1997 Nov 15;100(10):2552-61
references.pmid: 9366570
references.citation: J Immunol. 2000 Jul 1;165(1):397-403
references.pmid: 10861077
references.citation: Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7958-63
references.pmid: 11438742
references.citation: Am J Pathol. 2002 Nov;161(5):1669-77
references.pmid: 12414514
references.citation: J Clin Invest. 2003 Feb;111(3):333-40
references.pmid: 12569158
references.citation: J Immunol. 2002 Mar 1;168(5):2483-92
references.pmid: 11859142
references.citation: Circulation. 2003 Feb 25;107(7):1009-16
references.pmid: 12600915
references.citation: J Neuroimmunol. 2002 Apr;125(1-2):59-65
references.pmid: 11960641
references.citation: Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8075-80
references.pmid: 10869418
references.citation: Nat Immunol. 2006 Mar;7(3):311-7
references.pmid: 16462739
references.citation: J Clin Invest. 2007 Oct;117(10):2920-8
references.pmid: 17909628
references.citation: J Immunol. 2001 Jun 1;166(11):6477-82
references.pmid: 11359797
references.citation: Immunity. 2003 Jul;19(1):71-82
references.pmid: 12871640
references.citation: Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1547-52
references.pmid: 11381059
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10896-901
references.pmid: 9724801
references.citation: J Immunol. 2004 Apr 1;172(7):4410-7
references.pmid: 15034056
references.citation: Brain Res. 2003 Jul 25;979(1-2):65-70
references.pmid: 12850572
references.citation: Nat Neurosci. 2006 Jul;9(7):917-24
references.pmid: 16732273
references.citation: J Mol Med (Berl). 2005 Sep;83(9):672-81
references.pmid: 15827759
references.citation: J Leukoc Biol. 2002 Dec;72(6):1117-21
references.pmid: 12488492
references.citation: Invest Ophthalmol Vis Sci. 2003 Jan;44(1):22-31
references.pmid: 12506051
references.citation: J Exp Med. 2000 Oct 2;192(7):1075-80
references.pmid: 11015448
references.citation: Glia. 2001 Mar 1;33(3):256-66
references.pmid: 11241743
references.citation: Microsc Res Tech. 1997 Jan 1;36(1):1-16
references.pmid: 9031257
references.citation: J Neurosci Res. 2005 Aug 1;81(3):302-13
references.pmid: 15954124
references.citation: Glia. 1999 Dec;28(3):183-9
references.pmid: 10559777
references.citation: Nat Neurosci. 2005 Jun;8(6):752-8
references.pmid: 15895084
references.citation: Eur J Immunol. 2003 Feb;33(2):402-10
references.pmid: 12645937
references.citation: J Clin Invest. 2007 Jan;117(1):185-94
references.pmid: 17200718
references.citation: Methods. 2006 Feb;38(2):69-76
references.pmid: 16414268
references.citation: Mol Cell Biol. 2000 Jun;20(11):4106-14
references.pmid: 10805752
references.citation: Glia. 2000 Feb 15;29(4):305-15
references.pmid: 10652441
references.citation: Science. 2007 Aug 3;317(5838):666-70
references.pmid: 17673663
references.citation: Nat Rev Immunol. 2005 Dec;5(12):953-64
references.pmid: 16322748
references.citation: Glia. 1996 Jan;16(1):81-90
references.pmid: 8787776
references.citation: J Clin Invest. 2004 Mar;113(6):856-66
references.pmid: 15067318
references.citation: Science. 2005 May 27;308(5726):1314-8
references.pmid: 15831717